Systemic GLIPR1‐ΔTM protein as a novel therapeutic approach for prostate cancer

E-ISSN： 1097-0215|134|8|2003-2013

ISSN： 0020-7136

Source： INTERNATIONAL JOURNAL OF CANCER, Vol.134, Iss.8, 2014-04, pp. : 2003-2013

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Blocking 17β‐hydroxysteroid dehydrogenase type 1 in endometrial cancer: a potential novel endocrine therapeutic approach

THE JOURNAL OF PATHOLOGY, Vol. 244, Iss. 2, 2018-02 ,pp. : 203-214

John Wiley & Sons Inc

Access to resources Recommend Favorite

A novel therapeutic approach for LPIN1 mutation–associated rhabdomyolysis—The Austrian experience

MUSCLE AND NERVE, Vol. 52, Iss. 3, 2015-09 ,pp. : 437-439

John Wiley & Sons Inc

Access to resources Recommend Favorite

Novel approaches for the treatment of prostate cancer

By Arlen Philip M

Therapy, Vol. 5, Iss. 1, 2008-01 ,pp. : 1-2

Future Medicine

Access to resources Recommend Favorite

The polycomb group protein enhancer of zeste 2 is a novel therapeutic target for cervical cancer

CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (ELECTRONIC), Vol. 42, Iss. 5, 2015-05 ,pp. : 458-464

John Wiley & Sons Inc

Access to resources Recommend Favorite

CD147, MMP-1, MMP-2 and MMP-9 Protein Expression as Significant Prognostic Factors in Human Prostate Cancer

Oncology, Vol. 75, Iss. 3-4, 2008-10 ,pp. : 230-236

Karger

Access to resources Recommend Favorite